Location: Home > Pharma China Web Edition
  • search
  • go
  • News
  • 6/16/2025CARsgen Delivers Deep Responses with CT071 in Newly Diagnosed Multiple...
  • 6/16/2025Hengrui Presents Positive Phase 2 Obesity Data at ADA 2025
  • 6/16/2025NextCure and Simcere Zaiming Announce Strategic Partnership for a Nove...
  • 6/16/2025GlycoT Enters a License Deal with Innovent for ADC Technology
  • 6/14/2025Tianjin Slaps CNY 362M Fine for Drug Price-Fixing Scheme
  • 6/14/2025Keymed Biosciences' BsAb Shows Promise in Autoimmune Hemolytic Anemia
  • 6/13/2025Recent Executive Moves
  • 6/13/2025China Issues 2025 Action Plan to Combat Malpractice in Pharma Procure...
  • 6/13/2025Abbisko Therapeutics' Pimicotinib Earns NMPA Nod for TGCT NDA Review
  • 6/13/2025AB‑RayBio Secures Multi‑Million CNY Angel Investment
  • 6/13/2025AstraZeneca Enters Strategic Deal with CSPC Pharma Focused on AI-enabl...
  • 6/13/2025Nona and Visterra Partner to Advance Next-Gen Biotherapeutics for Immu...
  • 6/13/2025Kelun Cleared for Clinical Trial of SKB315 and Tagitanlimab Combo in C...
  • 6/12/2025Viatris Wins NMPA Approval for Once‑Daily Nebulized COPD Therapy Yupe...
  • 6/12/2025Hengrui Advances DLL3‑Targeting ADC SHR‑4849 with Phase II China Tri...
  • 6/12/2025CF PharmaTech Files for Hong Kong IPO
  • 6/12/2025Dizal to Showcase Breakthrough Data on Hematologic Oncology Assets at ...
  • 6/12/2025Cloudbreak Advances Ophthalmic Pipeline, Pursues Hong Kong IPO
  • 6/12/2025InnoVec Raises Tens of Millions in Series A+ to Accelerate Gene Therap...
  • 6/11/2025MediLink Therapeutics Lines Up Major Banks for Hong Kong IPO Push
  • 6/11/2025JW Pharma Wins China Approval for Ertapenem Injection
  • 6/11/2025Ligachem Inks Dual ADC Licensing Deals with CSPC Subsidiary Novarock
  • 6/11/20253Sbio Powers Ahead in PD-1/VEGF Bispecific Race with Impressive Phase ...
  • 6/10/2025BIOSeedin 2025 Showcases China's Rise as Global Biotech Innovator
  • 6/10/2025Pfizer CEO Highlights Chinese Data Due Diligence to Support $6B Bispec...
  • 6/10/2025Gavi Launches $224M Arbitration Claim Against Clover Biopharma Over CO...
  • 6/10/2025Merck KGaA's Pimicotinib NDA Accepted by CDE in China, Setting Course ...
  • 6/10/2025NH's DB6: China's Consumer Healthcare Market Underperformed Again in 2...
  • 6/10/2025CDE Seeks Comments on Draft Guidelines for Defining and Classifying Ad...
  • 6/10/2025CDE Seeks Public Feedback on Second Batch of 2025 External Expert Addi...
  • Page:8/54 Total number of articles:1606: [First][<<] [6] [7] [8] [9] [10] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group